159 related articles for article (PubMed ID: 8852700)
1. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7.
Thiermann H; Radtke M; Spöhrer U; Klimmek R; Eyer P
Arch Toxicol; 1996; 70(5):293-9. PubMed ID: 8852700
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.
Spöhrer U; Thiermann H; Klimmek R; Eyer P
Arch Toxicol; 1994; 68(8):480-9. PubMed ID: 7802588
[TBL] [Abstract][Full Text] [Related]
3. HLö 7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases.
Eyer P; Hagedorn I; Klimmek R; Lippstreu P; Löffler M; Oldiges H; Spöhrer U; Steidl I; Szinicz L; Worek F
Arch Toxicol; 1992; 66(9):603-21. PubMed ID: 1482283
[TBL] [Abstract][Full Text] [Related]
4. Effect of atropine and bispyridinium oximes on respiratory and circulatory function in guinea-pigs poisoned by sarin.
Worek F; Kirchner T; Szinicz L
Toxicology; 1995 Jan; 95(1-3):123-33. PubMed ID: 7825179
[TBL] [Abstract][Full Text] [Related]
5. The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine.
Clement JG; Bailey DG; Madill HD; Tran LT; Spence JD
Biopharm Drug Dispos; 1995 Jul; 16(5):415-25. PubMed ID: 8527690
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjector.
Nyberg AG; Cassel G; Jeneskog T; Karlsson L; Larsson R; Lundström M; Palmer L; Persson SA
Biopharm Drug Dispos; 1995 Nov; 16(8):635-51. PubMed ID: 8573684
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of toxogonin, HI-6 and HLö-7 on the release of [3H]acetylcholine from peripheral cholinergic nerves in rat airway smooth muscle.
Aas P
Eur J Pharmacol; 1996 Apr; 301(1-3):59-66. PubMed ID: 8773447
[TBL] [Abstract][Full Text] [Related]
8. Trimedoxime and HI-6: kinetic comparison after intravenous administration to mice.
Milic B; Maksimovic M; Nedelijkovic M
Pharmacol Toxicol; 1996 Apr; 78(4):269-72. PubMed ID: 8861786
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the acetylcholinesterase oxime reactivator, HI-6, in rhesus monkeys (Macaca mulatta): effect of atropine, diazepam, and methoxyflurane anesthesia.
Clement JG; Lee MJ; Simons KJ; Briggs CJ
Biopharm Drug Dispos; 1990 Apr; 11(3):227-32. PubMed ID: 2328309
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of antidotes (midazolam, atropine and HI-6) on nerve agent induced molecular and neuropathological changes.
RamaRao G; Afley P; Acharya J; Bhattacharya BK
BMC Neurosci; 2014 Apr; 15():47. PubMed ID: 24708580
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of the oxime HI-6 from a mixture with atropine sulphate in dogs.
Jovanović D; Kovacević V; Maksimović M
Pharmacol Toxicol; 1992 Nov; 71(5):340-2. PubMed ID: 1448446
[TBL] [Abstract][Full Text] [Related]
12. Effect of poisoning by soman (pinacolyl methylphosphonofluoridate) on the serum half-life of the cholinesterase reactivator HI-6 in mice.
Clement JG; Simons KJ; Briggs CJ
Biopharm Drug Dispos; 1988; 9(2):177-86. PubMed ID: 3370306
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic profile of promising acetylcholinesterase reactivators K027 and K203 in experimental pigs.
Karasova JZ; Kvetina J; Tacheci I; Radochova V; Musilek K; Kuca K; Bures J
Toxicol Lett; 2017 May; 273():20-25. PubMed ID: 28343895
[TBL] [Abstract][Full Text] [Related]
14. Intravenous application of HI-6 salts (dichloride and dimethansulphonate) in pigs: comparison with pharmacokinetics profile after intramuscular administration.
Zdarova Karasova J; Zemek F; Kunes M; Kvetina J; Chladek J; Jun D; Bures J; Tachecí I; Kuca K
Neuro Endocrinol Lett; 2013; 34 Suppl 2():74-8. PubMed ID: 24362096
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy of single or repeated HI-6 treatment following soman poisoning in guinea pigs and marmoset monkeys.
Busker RW; Zijlstra JJ; Philippens IH; Groen B; Melchers BP
Toxicology; 1996 Sep; 112(3):183-94. PubMed ID: 8845039
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in rats.
van Helden HP; van der Wiel HJ; Zijlstra JJ; Melchers BP; Busker RW
Arch Toxicol; 1994; 68(4):224-30. PubMed ID: 8067894
[TBL] [Abstract][Full Text] [Related]
17. HI-6 pharmacokinetics in rabbits after intravenous and intramuscular administration.
Lukey BJ; Woodard CL; Clark CR; McCluskey MP
J Pharm Pharmacol; 1992 Aug; 44(8):690-2. PubMed ID: 1359099
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice.
Clement JG; Shiloff JD; Gennings C
Arch Toxicol; 1987; 61(1):70-5. PubMed ID: 3326546
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and disposition kinetics of HI-6 in Beagle dogs.
Baggot JD; Buckpitt A; Johnson D; Brennan P; Chung H
Biopharm Drug Dispos; 1993 Mar; 14(2):93-105. PubMed ID: 8453028
[TBL] [Abstract][Full Text] [Related]
20. Atropine and oxime treatment in lethal soman poisoning of anaesthetized guinea-pigs: HLö 7 dimethanesulfonate versus HI 6 dichloride.
Worek F; Szinicz L
Pharmacol Toxicol; 1993 Jan; 72(1):13-21. PubMed ID: 8441735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
